Biosimilars in oncology: EHA 2017 session on rituximab
Paradigm-changing CAR T-cell therapy for multiple myeloma
Is denosumab superior to zoledronic acid in the treatment of bone metastases in MM?
iwNHL 2017: The future of lymphoma research and treatment
Catherine Bollard et al.
Investigating alternative treatments for non-reponsive lymphoma patients